Home Cart Sign in  
Chemical Structure| 1423715-37-0 Chemical Structure| 1423715-37-0

Structure of Seclidemstat
CAS No.: 1423715-37-0

Chemical Structure| 1423715-37-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Seclidemstat is a potent LSD1 inhibitor, with a mean IC50 of 127 nM.

Synonyms: SP-2577

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Seclidemstat

CAS No. :1423715-37-0
Formula : C20H23ClN4O4S
M.W : 450.94
SMILES Code : O=C(N/N=C(C1=CC(Cl)=CC=C1O)\C)C2=CC=CC(S(=O)(N3CCN(C)CC3)=O)=C2
Synonyms :
SP-2577
MDL No. :MFCD31630770
InChI Key :MVSQDUZRRVBYLA-HYARGMPZSA-N
Pubchem ID :135565033

Safety of Seclidemstat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Seclidemstat

epigenetics

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03600649 Ewing Sarcoma Phase 1 Recruiting August 2020 United States, California ... More >> Childrens Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Leo Mascarhenas, MD          Contact: Magnolia Manzano          United States, Florida Johns Hopkins All Children's Hospital Not yet recruiting Saint Petersburg, Florida, United States, 33701 Contact: Jessica Crimella          Principal Investigator: Jonathan Metts, MD          Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Tiffany Smith, MS, CRC          Principal Investigator: Damon Reed, MD          United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Morgan Krush          Principal Investigator: Steven Dubois, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Douglas Harrison, MD          Contact: Sherry Melton Less <<
NCT05266196 Ewing Sarcoma|Myxoid Liposarco... More >>ma|Desmoplastic Small Round Cell Tumor|Extraskeletal Myxoid Chondrosarcoma|Angiomatoid Fibrous Histiocytoma|Clear Cell Sarcoma|Myoepithelial Tumor|Low Grade Fibromyxoid Sarcoma|Sclerosing Epithelioid Fibrosarcoma Less << PHASE1|PHASE2 ENROLLING_BY_INVITATION 2025-12-25 Sarcoma Oncology Center, Santa... More >> Monica, California, 90403, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.22mL

0.44mL

0.22mL

11.09mL

2.22mL

1.11mL

22.18mL

4.44mL

2.22mL

References

 

Historical Records

Categories